Melanotan II
Non-selective melanocortin agonist producing rapid, deep tanning with significant libido enhancement and aphrodisiac effects.
Last updated: May 2026
Category
Tanning / Libido / Melanocortin
Frequency
Daily injection (loading) then maintenance
Research
Phase 2 CompletedWhat is Melanotan II?
Melanotan II (MT-2) is a synthetic cyclic analogue of alpha-MSH (alpha-melanocyte stimulating hormone) that binds to melanocortin receptors MC1R through MC5R. This multi-receptor binding is why MT-2 has such diverse effects. MC1R activation triggers melanin production (tanning). MC4R activation in the brain suppresses appetite and increases libido. The broad receptor profile produces faster, darker tanning than Melanotan I, plus pronounced effects on sexual function. Browse the full peptide library for related compounds.
MT-2 became widely known in the biohacking community not only for its dramatic tanning effect but also because its MC4 receptor activation produces significant aphrodisiac effects. Men experience spontaneous erections. Both sexes report increased sexual desire. This dual function is either a benefit or side effect depending on your goals.
What should you actually expect? Tanning effect becomes noticeable within 5 to 7 days of use, even with minimal sun exposure. Nausea is common in the first few doses but usually subsides. Libido increase is often reported, sometimes significantly. Appetite suppression is mild to moderate. Moles may darken. Facial flushing after injection is common and lasts 30 to 90 minutes. Be honest with yourself about whether the cosmetic appeal is worth the side effect reality.
On dosing: what the research and side-effect profile describe is a dose-dependent compound used in a loading-then-maintenance pattern, with nausea and facial flushing most pronounced early and easing as the body adjusts. Because the side effects scale with dose, published and clinical sources escalate gradually from a low starting point rather than beginning high. UV exposure accelerates the visible tanning but is not required for the melanin response. The specific dose, schedule, and how to manage side effects are decisions for a licensed prescriber, not a number to copy.
Safety considerations: MT-2 is one of the more side-effect-heavy peptides. Mole darkening requires monitoring. Any mole that changes shape or color should be seen by a dermatologist. The multi-receptor binding means unpredictable effects across different body systems. Not recommended for people with a history of melanoma or atypical moles. If you have significant mole history, stick to Melanotan I which is more selective.
In Vietnam, MT-2 is popular among expats in HCMC and Hanoi for the tanning effect in a tropical climate. Available research-grade from regional suppliers. For verified suppliers, see the supply index. Verify purity via the COA guide. For legal context, see the peptide legality guide.
How It Works
MC1 Activation (Tanning): Activates MC1 receptors on melanocytes, stimulating rapid, dense eumelanin production. The tan develops faster and darker than MT-1 due to greater receptor activation.
MC4 Activation (Sexual Effects): MC4 receptors in the brain hypothalamus regulate sexual function. Activation produces spontaneous erections in men and heightened sexual arousal in both genders. This is also why MT-2 causes appetite suppression.
MC3 Activation: Additional receptor activation in the CNS and peripheral tissues contributes to the broader side effect profile including nausea and energy changes.
Benefits
- Rapid, deep tan: often visible within 1 to 2 weeks
- Dramatic libido enhancement in both men and women
- Potential treatment for sexual dysfunction (studied for erectile dysfunction)
- Appetite suppression as a secondary effect
- Long-lasting tan: maintains with less frequent dosing than MT-1
Dosing Described in Research and Labels
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Melanocortin research | No established human dose | Subcutaneous (research) | Not established |
These figures summarise what published research and approved labels describe. They are educational, not a recommendation or a personal protocol. Any dose, schedule, or decision to use a compound belongs with a licensed prescriber.
Side Effects
Common
- ⚠Significant nausea (especially when starting: take at bedtime)
- ⚠Spontaneous erections in men (can be frequent and unwanted)
- ⚠Flushing (warmth and redness 30 to 90 min post-injection)
- ⚠Appetite suppression / decreased hunger
- ⚠Yawning and fatigue shortly after injection
- ⚠Darker, more numerous moles and freckles
Rare
- •Dizziness or fainting (from blood pressure changes)
- •Abdominal cramping
- •Prolonged erection (priapism): seek medical attention if over 4 hours
- •Changes to existing moles (monitor carefully)
Who Should NOT Use Melanotan II
- ✕History of melanoma or atypical moles
- ✕Personal or family history of skin cancer
- ✕Pregnancy or breastfeeding
- ✕Cardiovascular disease (BP effects)
- ✕Hormone-sensitive conditions
- ✕Under 18 years old
- ✕Not suitable for those who find sexual side effects unwanted
What to Expect
Take 100 to 250mcg at bedtime to sleep through nausea. Assess tolerance. Strong nausea, flushing, and possible erections should be expected.
Rapid tan develops with UV exposure. Significant appetite suppression. Sexual effects peak during loading. Take doses at bedtime to minimize nausea disruption.
Transition to maintenance dosing. Tan is well-established and maintained with weekly injections. Side effects diminish as dose frequency decreases.
Notes from Ho Chi Minh City
Melanotan-2 is a compound plenty of users try and then drop, because its multi-receptor profile produces side effects, nausea that can hit well after dosing, and a spontaneous-erection effect that is genuinely inconvenient in any professional setting. The tan develops faster than MT-1, often visible within a week, but the melanocortin agonism that drives it also carries a mole-darkening risk, which makes a regular dermatologist check non-negotiable rather than optional. On the Vietnam market, research-grade MT-2 runs 700k to 1.2 million VND per 10mg vial through cold-chain importers, cheaper than MT-1 because the synthesis is simpler. Given the dose-dependent side effects, dose and titration are decisions for a licensed prescriber, not a self-set number.
Sourcing in Vietnam
Melanotan-2 has no approved pharmaceutical brand in any country, including Vietnam. It is not stocked at Long Châu, Pharmacity, FV Hospital, or Vinmec. Sourcing is research-grade only through cold-chain importers (700k to 1.2 million VND per 10mg vial). Annual dermatologist mole monitoring is recommended given the broader melanocortin pathway activation profile compared to MT-1. See the supplier list and COA guide before purchasing.
FAQ
Q: How do I manage the nausea with MT-2?
A: The side-effect profile is dose-dependent: nausea tends to peak in the hours after a dose, which is why published protocols escalate gradually from a low starting point rather than beginning high. That is the pharmacology, not a prescription; the dose and how to manage side effects are decisions for a licensed prescriber.
Q: Is MT-2 safe for women?
A: The effects are reported in women as well, including the libido-related ones, and the side-effect profile is broadly similar, with no reproductive hormone disruptions reported at typical tanning exposures. Dosing is individual and dose-dependent, so it is a decision for a licensed prescriber rather than a set figure.
Q: How does MT-2 tan compare to MT-1?
A: MT-2 produces a faster and darker tan. MT-1 produces a more gradual, even tan. MT-2 also maintains the tan more easily with less frequent dosing than MT-1. The trade-off is MT-2 has significantly more side effects. For those who want a dramatic quick tan and can manage the side effects, MT-2 is more effective. Source from the community-verified supplier list.
Where to Get Melanotan II in Vietnam
See our community-verified supplier list with COA verification and cold-chain shipping to Vietnam.
Related Peptides
Research & Sources
- Melanotan II: Investigation of the safety and efficacy of melanotropic peptides · Dorr RT, Lines R, Levine N, et al. · Life Sciences (1996) PMID: 8632958
Foundational human safety and pharmacokinetic data for cyclic alpha-MSH analogue MT-II.
- Effects of an alpha-melanocyte-stimulating hormone analogue on penile erection and sexual desire · Wessells H, Fuciarelli K, Hansen J, et al. · Journal of Urology (1998) PMID: 9474194
Clinical demonstration of MC4R-mediated sexual function effects underlying both MT-II and PT-141 development.
- Adverse effects of melanotan II amongst Australian recreational users · Cardwell G, Wakefield C, Forbes J, et al. · Internal Medicine Journal (2017) PMID: 28675666
Real-world safety review documenting mole changes and unregulated supply risks in recreational use.
- Melanotan-induced melanoma: a case series and review · Cousen P, Colver G, Helbling I · Clinical and Experimental Dermatology (2009) PMID: 19778312
Documented melanoma case series following Melanotan use, supporting dermatological monitoring recommendations.
Important Disclaimer
Educational content only. Not medical advice. Peptides discussed on this page are not approved by Vietnam’s Ministry of Health (Bộ Y Tế) or the Drug Administration of Vietnam (DAV) for the indications described. Research peptides are not stocked at Long Châu, Pharmacity, or any retail pharmacy in Vietnam. Consult a licensed physician before any use.